Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients

Clinical trial NCT03351361 · COMPLETED

Trial details

NCT number: NCT03351361
Sponsor: Rennes University Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Non Small Cell Lung Cancer

Start date: 2018-02-19
Primary completion: 2021-07-31
Enrollment: 217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.